Yearly Archives: 2016
Showing articles 741 - 750 (1006 total)
04Apr1:02 pmEST
From Bobby's Room to Ivey's Room
There is a fairly clear rotation playing out today, with money coming out of some of the more prominent Nasdaq technology issues and rotating down to biotechnology and pharma stocks. Even with FANG names FB AMZN GOOGL NFLX off session lows as I write this, the QQQ ETF is still in the red while many biotechs squeeze higher off recent base...
04Apr10:38 amEST
Even a Bad Stallone Movie Has Its Moments
The stock of Cliffs Natural Resources Inc. has not been much of a, well, cliffhanger, in recent years. In fact, CLF has been soundly atrocious, declining from over $100 per share to a recent low of $1.20. The Cleveland-based iron ore miner sure did flirt with the potential of becoming an outright penny stock. But buyers have attempted to make...
03Apr3:44 pmEST
Weekend Overview and Analysis 04/03/16 {Video}
The following video is a brief, condensed version of the full-length Weekend Video Strategy Session which I present each weekend to members of Market Chess Subscription Services. In the longer version, I offer tons of actionable trade ideas, educational content, and in-depth objective analysis across all markets. Please click here for more...
02Apr9:20 pmEST
Saturday Night at Market Chess Cinemas
Rushmore (1998) is a light-hearted but sharp-tongued original comedy, starring Bill Murray and Jason Schwartzman as the memorable Max Fischer. I have great memories of the film, as I saw it in a packed theater right when it was released while I was in college, with a spirited crowd roaring to each scene. Directed by Wes Anderson and...
01Apr2:59 pmEST
April Fool's Surprise for These Markets
Despite crude oil gapping down hard (and staying weak throughout the sessions) and a green Japanese Yen (FXY), equity markets are ignoring those markets are holding onto their upside reversals from early on in the session. I see a good deal of charts firming up and setting bases off of which to explode, as long as the broad market continues to...
01Apr12:38 pmEST
They Looked Down and Got Squeezed
One of the more interesting themes of the current market has been whether he lagging biotechnology issues would being to play catch-up to the indices testing or surpassing their respective 200-day moving averages. To be sure, both the IBB (large cap) and XBI (more small and mid-cap) biotech ETFs are still a good deal below their own 200-day...
01Apr10:41 amEST
Musk: The Man and His Dream
The unveiling of the Tesla Model 3, marketed as an affordable electric car, initially seems to be a nightmare scenario for TSLA short sellers, of which they are plenty. An old-fashioned "sell the news" reaction to such seemingly positive events may be an obsolete concept in this day and age of Central Bankers allowing markets to bluff them off...
31Mar5:02 pmEST
Stock Market Recap 03/31/16 {Video}
The following video is a brief, condensed version of the Stock Market Recap which I present each evening to members of Market Chess Subscription Services. In the longer version, I offer tons of actionable trade ideas, educational content, and in-depth objective analysis across all markets. If you enjoy my videos and blog posts, then please...
31Mar3:07 pmEST
A Pyramid Scheme with a Flag
With VRX reversing sharply back down this afternoon, it is worth revisiting some scenarios where the market may force Bill Ackman's hand. Of course, this is not about calling out a talented and intelligent billionaire, but rather seeking out actionable ideas based on historical market patterns. Specifically, if Valeant continues to sell-off, an...
31Mar1:02 pmEST
This Market Leaves You to Your Own Devices
Medical devices, that is. The medical device space has been heating up of late, with some of the tightest charts in the market right now. Abiomed, below on the daily timeframe, is one such example. Note how ABMD saw price base tightly in recent sessions after its prior advance, with an enticing spike in buy volume on Tuesday. I am looking to...